SEC Form 4 · accession 0001209191-19-006557
ARATANA THERAPEUTICS, INC. · PETX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John C Ayres
Officer — SEE REMARKS
Period of report
Jan 30, 2019
Accepted (ET)
Feb 1, 2019 · 5:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001509190
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 30, 2019 | S | 3,125 | $4.19 | D | 129,889 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2018 and represents shares sold to satisfy the aggregate applicable tax withholdings owed in connection with the vesting of restricted stock. This sale constitutes the final sale under such trading plan.
Remarks
The Reporting Person is VP-Corporate Development and Administration, General Counsel and Secretary.